BioGaia AB (publ)
BIOG-B
Rank in Stocks
#7842
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Share Price
$13.86
Last synced: 2026-10-16
Market Cap
$1.37B
Change (1 day)
0.65%
Change (1 year)
23.21%
Country
SE
Trade BioGaia AB (publ) (BIOG-B)
Category
Healthcare
Market Capitalization of BioGaia AB (publ)(BIOG-B)
Market Cap: $1.37B
As of October 2026 BioGaia AB (publ) has a market cap of $1.37B. This makes BioGaia AB (publ) the world's 7842nd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioGaia AB (publ) from 2015 to 2026
BIOG-B compared with Top 5 Most Popular stocks
